QualityStocksNewsBreaks Archives - Page 26 of 1408

WednesdayJun 18, 2025 10:45 am

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia

Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS’ Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote land clearing and green waste sites, this marks MWS’s first shift to in-house, on-site drug testing for pre-employment, random, and for-cause purposes. The fingerprint-based system delivers non-invasive results in under ten minutes, enabling rapid safety decisions without disrupting field operations. INBS continues to expand its reach into safety-critical industries, with its scalable, sweat-based drug testing now in use by over 450 organizations across 24 countries.…

WednesdayJun 18, 2025 9:20 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the successful commercial manufacturing process scale-up of its lead product, Aversa™ Fentanyl, in collaboration with Kindeva, a global CDMO specializing in drug-device combinations. Aversa Fentanyl integrates Nutriband’s AVERSA™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch and is produced at Kindeva’s U.S.-based transdermal facility. The next step involves producing clinical supplies and submitting an Investigational New Drug application to begin a human abuse liability study. Nutriband projects Aversa Fentanyl, which aims to be the world’s first abuse-deterrent opioid patch, could achieve peak U.S. sales between $80 million and $200 million,…

WednesdayJun 18, 2025 9:10 am

QualityStocksNewsBreaks – GivBux Inc. (OTC: GBUX) Finalizes Deal to Acquire Charter House, Refocuses on Gold-Backed Fintech Expansion

GivBux (OTC: GBUX), a publicly traded Super App and charitable giving platform, announced it has finalized a Share Exchange Agreement to acquire 100% of Charter House Financial AU, with the transaction set to close by July 13, 2025. The acquisition marks a shift in GivBux's strategic focus toward gold-backed financial services, leveraging Charter House’s asset-backed infrastructure and global networks. The companies plan to integrate operations and jointly develop offerings that fuse precious metals with digital payments through the GivBux app. Charter House founder Anthony Capazze, a 25-year veteran in gold markets and finance, projected potential revenue of up to $200…

WednesdayJun 18, 2025 9:00 am

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf brand, announced that PGA TOUR Champions star Miguel Ángel Jiménez has officially joined the company and will play its Newton Fast Motion shaft, which he used to win the Principal Charity Classic. Jiménez’s playoff win in Iowa marked his 16th PGA TOUR Champions title and the second Tour victory for Newton’s Motion shaft line. The Fast Motion shaft, launched in April 2025, features advanced carbon fiber construction and proprietary performance technologies aimed at delivering speed, control, and consistency for golfers with moderate swing speeds. The win further validates Newton’s impact across professional…

TuesdayJun 17, 2025 9:10 am

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast

Intelligent Bio Solutions (NASDAQ: INBS) CEO Harry Simeonidis joined the latest episode of The BioMedWire Podcast to discuss the company’s rapid, non-invasive drug screening platform and global expansion strategy. Simeonidis detailed how the company’s fingerprint-based technology detects drug use through sweat, enabling faster and more affordable workplace screening. With current deployments in about 20 countries and an FDA application under review, Intelligent Bio Solutions is targeting U.S. market entry in the second half of 2025 and expects to scale through distributor partnerships and targeted marketing. To view the full article, visit https://ibn.fm/HZpfg About Intelligent Bio Solutions Inc. Intelligent Bio Solutions…

TuesdayJun 17, 2025 9:00 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring

HeartBeam to integrate AccurECG(TM), AccurKardia’s FDA-cleared ECG analysis software Collaboration enhances HeartBeam’s commercial offering with automated arrhythmia insights Combined platform aims to improve cardiac care access and speed time to diagnosis HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with AccurKardia, a leader in automated ECG diagnostics, to integrate its FDA-cleared AccurECG(TM) software into HeartBeam’s cable-free, credit card-sized 3D ECG device. The partnership unites two innovators in ambulatory cardiac monitoring to create a more scalable, accessible solution for arrhythmia detection and management. HeartBeam’s device captures electrical signals in three non-coplanar directions and synthesizes them into a 12-lead ECG for remote use.…

MondayJun 16, 2025 9:20 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its subsidiary HOPE Therapeutics announced a strategic investor relations partnership with astr partners, a boutique firm specializing in life sciences. The collaboration comes as NRx advances toward two NDA filings, an ANDA submission, and expands its interventional psychiatry clinic acquisitions. Led by veterans of The Trout Group, astr will support NRx and HOPE with investor targeting, message development, earnings prep, and institutional outreach to enhance visibility and engagement. To view the full press release, visit https://ibn.fm/6WIj9 About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on…

MondayJun 16, 2025 9:00 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG

HeartBeam’s credit card-sized device demonstrated 93.4% diagnostic agreement with standard ECGs VALID-ECG study results presented at Heart Rhythm Society conference Company eyes U.S. commercialization pending FDA clearance HeartBeam (NASDAQ: BEAT) announced its synthesized 12-lead ECG met clinical endpoints in the VALID-ECG pivotal study, achieving 93.4% diagnostic agreement with standard ECGs for arrhythmia assessment. The findings, presented by Dr. Thomas Deering of Piedmont Heart Institute at the Heart Rhythm Society’s annual meeting in San Diego, validate HeartBeam’s compact, patient-friendly ECG technology. The study compared ECG intervals and amplitudes between HeartBeam’s synthesized output and simultaneously collected standard ECGs in 198 patients across…

FridayJun 13, 2025 3:48 pm

QualityStocksNewsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Forest Hill Rd Project Adds to Growing Development Pipeline

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) was featured in a recent article that discussed its momentum with the development of its Forest Hill Rd solar project in upstate New York. “The 4.584 megawatt DC installation will operate as a community solar facility, contributing renewable energy to the local grid and offering cost savings to approximately 540 homes,” reads the article. “The project adds to SolarBank’s growing development pipeline, which now exceeds one gigawatt and already includes several solar projects in upstate New York. It also represents continued expansion in the U.S. market at…

FridayJun 13, 2025 3:01 pm

QualityStocksNewsBreaks – Driving the Future of Powersports: Massimo Group’s (NASDAQ: MAMO) Bold Strategy for Market Growth

As the powersports and recreational watercraft industries experience a notable upswing, Massimo Group (NASDAQ: MAMO) is taking a proactive approach through domestic manufacturing, strategic partnerships, and product diversification—initiatives that position the company to capitalize on emerging opportunities. Fueled by growing consumer enthusiasm for outdoor recreation and the multi-purpose appeal of vehicles like those in Massimo’s lineup, the global powersports market—valued at $37.96 billion in 2023—is expected to reach $60.51 billion by 2032. Founded in 2009 and headquartered in Garland, Texas, Massimo Motor has aligned itself with these trends through a broad product line that includes UTVs, ATVs, e-bikes and pontoon boats, catering…

Site Search

Company Search

Category: QualityStocksNewsBreaks